Acupuncture and electroacupuncture on Chemotherapy-Induced Peripheral Neuropathy

A comparative study of acupuncture and electroacupuncture on Chemotherapy-Induced Peripheral Neuropathy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0003178

Enrollment

Registered

2018-09-12

Start date

2018-09-10

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : acupuncture :Single-use, sterile, filiform acupuncture needles, 0.20mm in diameter and 30 mm in length (Dongbang Co.,Seoul, Korea.) battary-operated EA device : HA-306 (Hanil TM, Kore

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. age 18 years or over, 80 years or below 2. who has finished chemotherapy and has been over 3 months with CIPN 3. who is over Grade ?in CIPN condition 4. who is able to follow-up for the duration of the study, agreed to keep the restriction rule during the study. 5. accord with the washout criteria and agreed to keep the restriction rule during the study. 6. provided written informed consent, voluntarily

Exclusion criteria

Exclusion criteria: 1. taking other alternative therapy such as herbs, high-dose vitamin therapy. 2. who has diabetic neuropathy 3. patients with advanced cancer or metastatic cancer 4. who takes medicine like antiepileptic or pain killers which might affects neuropathy. Except those who take conventional medicine over 1 month without dose-change such as TCA, carbamazepine, gabapentine, opiate etc. 5. who needs surgery due to paralysis or nerologocal symptoms. 6. who has liver or kidney dysfunction : over 3 times of limits in blood chemistry.(AST, ALT, BUN, Creatinine) 7. leukopenia (WBC<4,000 /?) , or neutropenia(neutro < 1,500/?) 8. thrombocytopenia (platelet < 50,000 /?) or who takes heparine or cumarine. 9. childbearing age (Urine HGC positive) or who doesn't agree with contraception 10. who has pacemaker due to heart disease 11. inappropriate in this study confirmed by researchers

Design outcomes

Primary

Measure	Time frame
NPSI(Neuropathic Pain Symptom Inventory) ,;VAS (Visual Analogue Scale)	—

Secondary

Measure	Time frame
EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer Qulity of life questionnaire - CIPN 20);Blood chemistry	—

Countries

Korea, Republic of

Contacts

Public ContactMinah Kwak

Daegu Oriental Hospital of Daegu Haany University

nari003@hanmail.net+82-53-770-2111

Outcome results